CNSP Stock Price Prediction 2026
CNS Pharmaceuticals, Inc. Common Stock
AI-powered price predictions based on fundamental analysis and growth projections
- MACD converging near zero line - potential energy building
- Volume showing distribution (CMF: -0.2112)
- Recent pattern: Doji - Indecision pattern
- Price near support at $5.57
Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 186.7% upside potential.
Volume Trend: Distribution
Selling Pressure Present - Distribution pattern observed
Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.
| Timeframe | Target Price | Potential Return |
|---|---|---|
| 30 Days | $6.73 | +20.7% |
| 90 Days | $9.19 | +64.6% |
| 6 Months | $12.79 | +129.2% |
| 1 Year | $20.00 | +258.4% |
More CNSP Analysis
Scenario Analysis (1-Year Outlook)
Best case scenario if strong fundamentals and market conditions align
Expected scenario based on current growth trajectory
Downside scenario if market headwinds or disappointing results